Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder

H H Schmidt1, H Pirc-Danoewinata, E R Panzer-Grümayer

  • 1Department of Internal Medicine, University of Graz, Austria.

Insights

This study details a rare case of large granular lymphocyte (LGL) leukemia in a 67-year-old patient. A novel t(3;5) translocation was identified, suggesting a new mechanism in T-cell leukemia development.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Large granular lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder.
  • Understanding the genetic underpinnings of LGL leukemia is crucial for diagnosis and treatment.

Observation:

  • A 67-year-old patient presented with LGL leukemia.
  • Fluorescence-activated cell sorting (FACS) revealed a CD3+, CD4+, CD5+, CD29+, CD45RA+, CD57+, TCR alpha/beta+ lymphocyte population.
  • Bone marrow examination showed no lymphocyte infiltration.

Findings:

  • Cytogenetic analysis identified a novel karyotype: 46,XY,t(3;5)(p26;q13).
  • Molecular analysis confirmed rearrangement of the gamma-T-cell-receptor chain.
  • The translocation involves the 3p25-3p26 region, known to harbor tumor suppressor and oncogenes.

Implications:

  • This newly described translocation may represent an alternative mechanism in the pathogenesis of T-cell leukemia.
  • Further research into this translocation could provide new insights into LGL leukemia development.
  • Identifying novel genetic alterations is key to advancing targeted therapies for leukemia.

Related Concept Videos